This information collection covers the
third-party disclosures associated with section 502 (21 U.S.C. 352)
of the Federal Food, Drug, and Cosmetic Act, which, among other
things, establishes requirements that the label or labeling of a
medical device must meet so that it is not misbranded and subject
to regulatory action.
The number of disclosures has
decreased from 1,000 to 404 due to a decrease in the number of SUDs
listed by reprocessors. This adjustment has resulted in a 60-hour
decrease of the total hour burden.
$90,000
No
No
No
No
No
Uncollected
Daniel Gitteson 3017965156
daniel.gitteson@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.